Vanda Pharmaceuticals Inc (VNDA)
5.09
+0.15
(+3.04%)
USD |
NASDAQ |
Nov 22, 16:00
5.105
+0.02
(+0.29%)
After-Hours: 20:00
Vanda Pharmaceuticals Free Cash Flow: -18.20M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -18.20M |
| June 30, 2024 | -5.533M |
| March 31, 2024 | -11.77M |
| December 31, 2023 | 12.42M |
| September 30, 2023 | 25.56M |
| June 30, 2023 | 40.32M |
| March 31, 2023 | 59.09M |
| December 31, 2022 | 31.30M |
| September 30, 2022 | 48.62M |
| June 30, 2022 | 45.34M |
| March 31, 2022 | 58.57M |
| December 31, 2021 | 63.66M |
| September 30, 2021 | 55.52M |
| June 30, 2021 | 55.25M |
| March 31, 2021 | 60.32M |
| December 31, 2020 | 49.98M |
| September 30, 2020 | 41.37M |
| June 30, 2020 | 37.94M |
| March 31, 2020 | 34.40M |
| December 31, 2019 | 44.93M |
| September 30, 2019 | 50.45M |
| June 30, 2019 | 53.30M |
| March 31, 2019 | 12.36M |
| December 31, 2018 | 4.618M |
| September 30, 2018 | -7.348M |
| Date | Value |
|---|---|
| June 30, 2018 | -14.11M |
| March 31, 2018 | 3.691M |
| December 31, 2017 | -3.647M |
| September 30, 2017 | -8.802M |
| June 30, 2017 | -9.957M |
| March 31, 2017 | -10.45M |
| December 31, 2016 | -9.51M |
| September 30, 2016 | -8.70M |
| June 30, 2016 | -15.07M |
| March 31, 2016 | 0.251M |
| December 31, 2015 | 9.922M |
| September 30, 2015 | -2.732M |
| June 30, 2015 | -4.659M |
| March 31, 2015 | -53.51M |
| December 31, 2014 | -90.32M |
| September 30, 2014 | -88.85M |
| June 30, 2014 | -91.48M |
| March 31, 2014 | -62.66M |
| December 31, 2013 | -39.77M |
| September 30, 2013 | -41.37M |
| June 30, 2013 | -41.28M |
| March 31, 2013 | -45.55M |
| December 31, 2012 | -46.93M |
| September 30, 2012 | -45.51M |
| June 30, 2012 | -42.54M |
Free Cash Flow Range, Past 5 Years
-18.20M
Minimum
Sep 2024
63.66M
Maximum
Dec 2021
36.45M
Average
43.15M
Median
Free Cash Flow Benchmarks
| Zevra Therapeutics Inc | -69.57M |
| Black Diamond Therapeutics Inc | -61.20M |
| Edgewise Therapeutics Inc | -110.10M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.58M |
| Cash from Investing (Quarterly) | 12.06M |
| Free Cash Flow Per Share (Quarterly) | -0.253 |
| Free Cash Flow to Equity (Quarterly) | -14.74M |
| Free Cash Flow to Firm (Quarterly) | -14.74M |
| Free Cash Flow Yield | -6.17% |